» Articles » PMID: 36648449

Inactivation of Growth Differentiation Factor 9 Blocks Folliculogenesis in Pigs†

Overview
Journal Biol Reprod
Date 2023 Jan 17
PMID 36648449
Authors
Affiliations
Soon will be listed here.
Abstract

Growth differentiation factor 9 (GDF9) is a secreted protein belonging to the transforming growth factor beta superfamily and has been well characterized for its role during folliculogenesis in the ovary. Although previous studies in mice and sheep have shown that mutations in GDF9 disrupt follicular progression, the exact role of GDF9 in pigs has yet to be elucidated. The objective of this study was to understand the role of GDF9 in ovarian function by rapidly generating GDF9 knockout (GDF9-/-) pigs by using the CRISPR/Cas9 system. Three single-guide RNAs designed to disrupt porcine GDF9 were injected with Cas9 mRNA into zygotes, and blastocyst-stage embryos were transferred into surrogates. One pregnancy was sacrificed on day 100 of gestation to investigate the role of GDF9 during oogenesis. Four female fetuses were recovered with one predicted to be GDF9-/- and the others with in-frame mutations. All four had fully formed oocytes within primordial follicles, confirming that knockout of GDF9 does not disrupt oogenesis. Four GDF9 mutant gilts were generated and were grown past puberty. One gilt was predicted to completely lack functional GDF9 (GDF9-/-), and the gilt never demonstrated standing estrus and had a severely underdeveloped reproductive tract with large ovarian cysts. Further examination revealed that the follicles from the GDF9-/- gilt did not progress past preantral stages, and the uterine vasculature was less extensive than the control pigs. By using the CRISPR/Cas9 system, we demonstrated that GDF9 is a critical growth factor for proper ovarian development and function in pigs.

Citing Articles

Protective effect of luteinizing hormone on frozen-thawed ovarian follicles and granulosa cells.

Chen J, Yu B, Zhang S, Wang Z, Dai Y PLoS One. 2025; 20(1):e0317416.

PMID: 39808671 PMC: 11731763. DOI: 10.1371/journal.pone.0317416.

References
1.
Carabatsos M, Elvin J, Matzuk M, Albertini D . Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol. 1999; 204(2):373-84. DOI: 10.1006/dbio.1998.9087. View

2.
Koppes E, Redel B, Johnson M, Skvorak K, Ghaloul-Gonzalez L, Yates M . A porcine model of phenylketonuria generated by CRISPR/Cas9 genome editing. JCI Insight. 2020; 5(20). PMC: 7605535. DOI: 10.1172/jci.insight.141523. View

3.
Yan C, Wang P, DeMayo J, Demayo F, Elvin J, Carino C . Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001; 15(6):854-66. DOI: 10.1210/mend.15.6.0662. View

4.
Lee K, Kwon D, Ezashi T, Choi Y, Park C, Ericsson A . Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci U S A. 2014; 111(20):7260-5. PMC: 4034252. DOI: 10.1073/pnas.1406376111. View

5.
Qin Y, Tang T, Li W, Liu Z, Yang X, Shi X . Bone Morphogenetic Protein 15 Knockdown Inhibits Porcine Ovarian Follicular Development and Ovulation. Front Cell Dev Biol. 2019; 7:286. PMC: 6877722. DOI: 10.3389/fcell.2019.00286. View